Logo image of COO.CA

OSTROM CLIMATE SOLUTIONS INC (COO.CA) Stock Fundamental Analysis

TSX-V:COO - TSX Venture Exchange - CA6886041079 - Common Stock - Currency: CAD

0.05  +0.02 (+42.86%)

Fundamental Rating

1

Overall COO gets a fundamental rating of 1 out of 10. We evaluated COO against 15 industry peers in the Health Care Equipment & Supplies industry. COO has a bad profitability rating. Also its financial health evaluation is rather negative. COO has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

COO had negative earnings in the past year.
In the past year COO has reported a negative cash flow from operations.
In multiple years COO reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: COO reported negative operating cash flow in multiple years.
COO.CA Yearly Net Income VS EBIT VS OCF VS FCFCOO.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1M -1M -2M

1.2 Ratios

The Return On Assets of COO (-105.51%) is worse than 66.67% of its industry peers.
Industry RankSector Rank
ROA -105.51%
ROE N/A
ROIC N/A
ROA(3y)-42.64%
ROA(5y)-15.37%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
COO.CA Yearly ROA, ROE, ROICCOO.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 100 150

1.3 Margins

COO has a Gross Margin (41.56%) which is in line with its industry peers.
In the last couple of years the Gross Margin of COO has declined.
The Profit Margin and Operating Margin are not available for COO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 41.56%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.58%
GM growth 5Y-8%
COO.CA Yearly Profit, Operating, Gross MarginsCOO.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 -40 60 -60

More info and screens

0

2. Health

2.1 Basic Checks

COO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, COO has more shares outstanding
The number of shares outstanding for COO has been increased compared to 5 years ago.
The debt/assets ratio for COO has been reduced compared to a year ago.
COO.CA Yearly Shares OutstandingCOO.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M
COO.CA Yearly Total Debt VS Total AssetsCOO.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M

2.2 Solvency

COO has an Altman-Z score of -13.19. This is a bad value and indicates that COO is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of COO (-13.19) is worse than 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -13.19
ROIC/WACCN/A
WACC8.25%
COO.CA Yearly LT Debt VS Equity VS FCFCOO.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1M -1M -2M

2.3 Liquidity

A Current Ratio of 0.46 indicates that COO may have some problems paying its short term obligations.
COO has a worse Current ratio (0.46) than 66.67% of its industry peers.
COO has a Quick Ratio of 0.46. This is a bad value and indicates that COO is not financially healthy enough and could expect problems in meeting its short term obligations.
COO has a Quick ratio of 0.37. This is in the lower half of the industry: COO underperforms 60.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.46
Quick Ratio 0.37
COO.CA Yearly Current Assets VS Current LiabilitesCOO.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for COO have decreased strongly by -152.04% in the last year.
The Revenue has grown by 52.61% in the past year. This is a very strong growth!
The Revenue has been growing by 8.65% on average over the past years. This is quite good.
EPS 1Y (TTM)-152.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-24.29%
Revenue 1Y (TTM)52.61%
Revenue growth 3Y24.46%
Revenue growth 5Y8.65%
Sales Q2Q%186.6%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
COO.CA Yearly Revenue VS EstimatesCOO.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M 5M
COO.CA Yearly EPS VS EstimatesCOO.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

COO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
COO.CA Price Earnings VS Forward Price EarningsCOO.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
COO.CA Per share dataCOO.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 0.04

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

COO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OSTROM CLIMATE SOLUTIONS INC

TSX-V:COO (2/12/2025, 7:00:00 PM)

0.05

+0.02 (+42.86%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-28 2024-11-28
Earnings (Next)04-28 2025-04-28
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners26.4%
Ins Owner ChangeN/A
Market Cap5.70M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.06
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.03
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.05
BVpS-0.03
TBVpS-0.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -105.51%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 41.56%
FCFM N/A
ROA(3y)-42.64%
ROA(5y)-15.37%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.58%
GM growth 5Y-8%
F-Score2
Asset Turnover2.09
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 6.91%
Cap/Sales 0.08%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.46
Quick Ratio 0.37
Altman-Z -13.19
F-Score2
WACC8.25%
ROIC/WACCN/A
Cap/Depr(3y)75.24%
Cap/Depr(5y)56.21%
Cap/Sales(3y)0.36%
Cap/Sales(5y)0.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-152.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-24.29%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)52.61%
Revenue growth 3Y24.46%
Revenue growth 5Y8.65%
Sales Q2Q%186.6%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-161.98%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-73.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-79.2%
OCF growth 3YN/A
OCF growth 5YN/A